Li Zhangzhen hurriedly brought Gan Hu, the general manager of Huarui Pharmaceutical, to Huarui Laboratory with the company's lawyer and a full set of documents from the newly established Huarui Pharmaceutical.

Ganhu was dug up by Li Zhangzhen in Hong Kong. In terms of resume, it is indeed lacking. The most conspicuous work experience is just a few years of workshop experience in the factory of a well-known pharmaceutical company, and a few years of wasted in the office...

Li Zhangzhen also knew that the person he chose was not very satisfactory, so he could only explain from the side: "Time is tight, we are a new company, and there is no particularly suitable person under the headhunter."

"How much is the salary?"

"If you work in mainland China for 15,000 yuan, you will have to add another 3,000 yuan subsidy, and twice a year round-trip air tickets." Li Zhangzhen said and quickly added: "In fact, if you build a pharmaceutical factory in Hong Kong, it will be better to recruit people..."

"The workers trained by the West Jet Factory are not just for this time." Yang Rui immediately rejected Li Zhangzhen's suggestion and said: "Let's use Ganhu first. It depends on his level at that time. You can continue to supervise Huarui Pharmaceutical's work and report to me at any time."

"Don't worry. I will be optimistic." Li Zhangzhen focused on the focus. Yang Rui's energy was always focused on scientific research, which gave him great autonomy in the company. Li Zhangzhen knew in his heart that this rare window period would not last too long. Just like the lawyer Yue Ting was gradually eroding the territory of the small lawyers originally hired by the company, Huarui Company would definitely recruit more and more professional managers in the future. If Li Zhangzhen hopes to maintain his position, he has to work harder.

Trust is his biggest asset.

"Call Ganhu in for tea." Yang Rui sat back on his teahouse, opened a pack of Zhengshan small seeds, and slowly boiled water.

After a while, Gan Hu walked into Huarui Laboratory with curiosity.

This is a thin middle-aged man, a bit like the real tiger in "Wu Song" that Yang Rui watched, and the small one is like a leopard.

"Come here to have tea." Yang Rui greeted and said, "I am the head of Huarui Laboratory, a mainlander, and am currently in charge of the preparation and construction of Huarui Pharmaceutical. The next deferrosterone that Huarui Pharmaceutical will do is developed by me."

Yang Rui didn't say that he was the big boss behind him, but he still let Gan Hu understand that he was his superior.

Gan Hu shook hands politely with Yang Rui, sat down at the stool opposite him, and smiled and said, "I know, you have the right to make a decision."

"There are now, and there are later, so you have to cooperate with my work, not the other way around."

Ganhu looked at Li Zhangzhen, and Li Zhangzhen nodded to confirm.

"I understand." Although Ganhu was unwilling to give up, he also agreed. There are two types of internal structures of pharmaceutical companies, one is a laboratory-cooperated factory, and the other is a factory-cooperated laboratory.

Yang Rui's words mean that Huarui Pharmaceutical is a factory-cooperated laboratory model. Although Ganhu doesn't feel comfortable, he can only agree.

Unlike ordinary people's intuition, most pharmaceutical companies are actually laboratories and factories, especially domestic and Hong Kong pharmaceutical companies.

If you think about it carefully, it is actually easy to understand that most of the pharmaceutical companies in countries around the world, including domestic and Hong Kong, as well as American imperialism, are generic drug companies. The difficulties faced by generic drug companies are different from those of original drug companies. The difficulties of original drug companies usually lie in what structure compounds can cure diseases and why, while the difficulties of generic drugs usually only lie in how to make compounds of this structure.

The remaining part has been completed by the original pharmaceutical company for the generic pharmaceutical company.

Generic drugs are counterfeit companies among pharmaceutical companies. Although due to the strict system of drug protection, original drug companies can obtain drug monopoly and recover costs within several years, generic drug companies can also use this time to make generic research.

Compared with pharmacokinetics and clinical trials, it is really too easy to synthesize compounds just by simply synthesising them.

Taking India as an example, their compulsory patent system can be made immediately after the court issued a compulsory patent order. This is naturally not because their laboratories are stronger than those of European and American laboratories, but because the key to pharmaceuticals is not drug synthesis.

Ganhu's previous company was a generic drug company and had never been in contact with an original drug company with laboratory as its core. At this time, he could only speak silently and wait until he knew the situation later.

However, Yang Rui's request was not the same. He introduced the deferrosterone situation to Ganhu and Li Zhangzhen. Before the excitement of the two men faded, he said: "I have contacted Jilikang. Your next task is to seize the time to cooperate with Jilikang."

Ganhu's face changed: "Gericang in the UK?"

"That's right."

"Do you want to sell ferrosterone to the British?" Ganhu asked naturally. Jellicon is a multinational pharmaceutical company and ranks among the top in original pharmaceutical companies. Such a company is almost incomparable to the newly established Huarui Pharmaceutical, and there is almost no cooperation.

Yang Rui thought about it and said, "My original intention is to use Jielikan's resources to train the team and let you familiarize yourself with the entire process of drug declaration. Of course, if Jielikan is willing to offer a good price to buy a patent for ferrosterone, I think it's OK. Huarui Pharmaceutical will do the next project."

In Yang Rui's eyes, deferrosterone is just a rare drug that is not very profitable. The competition for deferrosterone is really not profitable. In fact, Yang Rui did not want to make money by deferrosterone. Solving the dilemma of thalassemia patients is the first priority. Since this is the case, if Jielikon is interested, this large pharmaceutical company can promote the listing of deferrosterone faster and reduce production costs.

Ganhu was full of questions, and the most important thing was to pick up: "Is Jielikang willing to cooperate with us? Isn't it a direct acquisition?"

"The relationship between Huarui and Jielikan is quite special, and Jielikan has agreed to cooperate." Yang Rui doesn't care about this issue.

If Jielikang had a store bullying customers before, it would be meaningless since Yang Rui made the additive of Coenzyme Q10.

It should be said that Jielikan did not chase Yang Rui's butt and asked for the additives of Coenzyme Q10. It was the result of their suppression of impulse and the bureaucracy was overwhelming.

Of course, the most important thing is that Jelikon is negotiating with rivals from Japan and Norway at the same time.

With Yang Rui taking the absolute initiative, multiple companies in three countries did not pounce on them like flies that smelled meat. To be precise, at the beginning, when Yang Rui's catalyst formula was still fresh meat, many companies had pounced on them. The Japanese and Norwegians even intercepted Yang Rui at the airport, trying to get this huge profitable catalyst patent at a lower price.

But after Yang Rui showed a big appetite, the companies suppressed their impulses and started negotiations with each other.

This is also a common scene in pharmaceutical groups. Pharmaceutical companies are always one, especially large original pharmaceutical companies. They are particularly terrible. They will not easily negotiate in the downturn and always try their best to seize the right to speak.

For Yang Rui's catalyst formula, if you follow Jielikan's bottom line, you can get the dividend of US$12 million and 2% of US dollars, Jielikan will naturally pay without hesitation and defeat the Japanese company with it.

But Yang Rui's appetite has exceeded 5% of sales dividends, which is not something that Jilikon can accept.

The formula of a mere catalyst, neither invested nor participated in the operation, would take away 5% of the revenue of the entire Coenzyme Q10 industry, which is comparable to tax revenue.

Several pharmaceutical companies would rather negotiate with each other, regardless of whether the result could be reached, but at least they could reduce the price to Yang Rui.

Anyway, no one uses catalysts, and we can still maintain the current situation.

Two months can basically be considered instant for large pharmaceutical companies.

But for individuals, this can be called a torment.

Even Yang Rui couldn't help it.

But he could not ask Jielikan directly to avoid showing guilt.

If you use the cooperation of "deferrosterone" to test it, it will be much more tactful.

Frankie, who came in a hurry, couldn't even say whether Yang Rui was really trying.

After all, it is well known that pharmaceutical companies like Jilikang have a deep respect for this - even the world's top pharmaceutical companies do not produce new drugs every year, especially non-improved pure original drugs, which is extremely rare. Every successful development, every successful launch, or even every phased clinical trial success means hundreds of high-paying positions waiting for them.

It would be nonsense to say that Yang Rui made an original medicine just for the sake of testing.

Frank himself didn't believe it.

When he came to Huarui Laboratory, Frank briefly reviewed Yang Rui's experimental records, but had to believe it and said, "I don't really understand the work you do, but I did four experiments to complete the synthesis. Isn't it a bit too simple, right?"

"That's because the difficult part has not started yet. I want to ask Jielikan to cooperate. Are you willing?"

"I can make a call, I don't have the right to decide, but if it does work as you said, I think it's okay." Franky looked at Yang Rui under the white coat with a look of Superman, and turned around to make the call.
Chapter completed!